Oscar Health, Inc.
OSCR
$12.03
-$0.32-2.59%
NYSE
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 9.16B | 8.20B | 7.21B | 6.51B | 5.84B |
| Total Other Revenue | 20.58M | 21.49M | 22.13M | 21.98M | 21.35M |
| Total Revenue | 9.18B | 8.22B | 7.23B | 6.54B | 5.86B |
| Cost of Revenue | 7.33B | 6.47B | 5.63B | 5.11B | 4.64B |
| Gross Profit | 1.84B | 1.74B | 1.60B | 1.43B | 1.22B |
| SG&A Expenses | 1.76B | 1.65B | 1.52B | 1.42B | 1.43B |
| Depreciation & Amortization | 32.15M | 30.65M | 32.35M | 33.57M | 30.69M |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 9.12B | 8.16B | 7.18B | 6.56B | 6.10B |
| Operating Income | 57.27M | 59.52M | 49.65M | -24.69M | -235.62M |
| Income Before Tax | 33.43M | 36.47M | 24.00M | -51.22M | -267.30M |
| Income Tax Expenses | 7.31M | 6.90M | 5.74M | 2.27M | 3.29M |
| Earnings from Continuing Operations | 26.12 | 29.57 | 18.25 | -53.48 | -270.59 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -689.00K | -619.00K | -106.00K | -104.00K | -134.00K |
| Net Income | 25.43M | 28.95M | 18.15M | -53.59M | -270.73M |
| EBIT | 57.27M | 59.52M | 49.65M | -24.69M | -235.62M |
| EBITDA | 89.41M | 90.17M | 81.99M | 8.87M | -204.92M |
| EPS Basic | 0.16 | 0.12 | 0.05 | -0.26 | -1.21 |
| Normalized Basic EPS | 0.12 | 0.09 | 0.05 | -0.16 | -0.75 |
| EPS Diluted | -0.08 | -0.06 | -0.13 | -0.40 | -1.21 |
| Normalized Diluted EPS | -0.02 | -0.05 | -0.09 | -0.26 | -0.75 |
| Average Basic Shares Outstanding | 961.43M | 940.30M | 920.30M | 901.02M | 886.49M |
| Average Diluted Shares Outstanding | 1.09B | 1.07B | 1.05B | 963.38M | 886.49M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |